Biosense Webster, a part of Johnson & Johnson MedTech, has announced that several products in its cardiac ablation portfolio have received approval for a zero fluoroscopy workflow from the FDA. The products that can be used in this workflow include:
- THERMOCOOL SMARTTOUCH™ SF catheter – the most commonly used ablation catheter in the world for RF ablation
- THERMOCOOL SMARTTOUCH™ Catheter
- CARTO® VIZIGO® Bi-Directional Guiding Sheath
- PENTARAY® NAV ECO High Density Mapping Catheter
- DECANAV® Mapping Catheters
- Webster® CS Catheter
The updated workflow indicates that direct imaging guidance, such as ultrasound, may be used as an alternative to fluoroscopy.